Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06500260 · ClinicalTrials.gov registry record
CNKSR2 Natural History Study
A clinical trial of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT06500260: Recruiting study of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset, sponsored by University of California, San Francisco.
NCT06500260 is a study of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06500260, a study of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective natural history study is being conducted to define the electroclinical, neurodevelopmental, and behavioral characteristics of CNKSR2 epilepsy aphasia syndrome (EAS) and intellectual disability (ID) in children aged 6 to 21 years old with CNKSR2 mutations. The data collected from this study will serve as an external control to eventual clinical trials examining precision medicine investigational therapeutics that aim to improve the seizure burden and neurodevelopmental outcomes in patients with CNKSR2 EAS/ID.
Primary Outcome
Functional connectivity is unitless.
Conditions Studied
Study Locations (1)
California
- University of California, San Francisco (UCSF) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2025-12-31 |
What NCT06500260 shows while recruiting
NCT06500260 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 3 conditions, with Developmental Dysphasia appearing as the primary indexed condition, and to 0 interventions.
NCT06500260 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06500260 about?
NCT06500260 is a clinical study titled "CNKSR2 Natural History Study". This prospective natural history study is being conducted to define the electroclinical, neurodevelopmental, and behavioral characteristics of CNKSR2 epilepsy aphasia syndrome (EAS) and intellectual disability (ID) in children aged 6 to 21 years old with CNKSR2 mutations. The data collected from th...
What is the current status of trial NCT06500260?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2022-01-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06500260 study?
This clinical trial studies the following conditions: Developmental Dysphasia, Epileptic Encephalopathy, Childhood-Onset, X-Linked Intellectual Disability.
Who is sponsoring clinical trial NCT06500260?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06500260 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI